Related Experiment Videos
UCI-VULV-1, a vulvar squamous carcinoma cell line
P M Carpenter1, G Gamboa-Vujicic, J T Mascarello
1Department of Pathology University of California, Irvine 92668, USA.
Gynecologic Oncology
|May 1, 1995
Summary
This study introduces the UCI-VULV-1 cell line, derived from a squamous vulvar carcinoma metastasis. This HPV-negative cell line shows sensitivity to cis-platinum, offering a new model for HPV-negative vulvar cancer research.
Area of Science:
- Oncology
- Cell Biology
- Gynecologic Pathology
Background:
- Squamous vulvar carcinoma (SCV) is an uncommon neoplasm with uncertain etiology, presenting distinct HPV-associated and HPV-negative subtypes.
- Characterizing the HPV-negative subtype is crucial for understanding SCV heterogeneity and developing targeted therapies.
Observation:
- The UCI-VULV-1 cell line was established from a lymph node metastasis of SCV.
- This cell line exhibits specific growth characteristics, including a 60-hour doubling time and a saturation density of 10(5) cells/cm2.
- Morphologically, cells range from spindle-shaped to larger, flat cells, with differential keratin expression and no anchorage independence.
Findings:
- UCI-VULV-1 cells are HPV-negative, confirmed by polymerase chain reaction.
- Immunoreactivity for high-molecular-weight keratin is universal, while low-molecular-weight keratin is present only in flat cells.
- The cell line expresses epidermal growth factor (EGF), transforming growth factor-alpha, EGF receptor, and p53 protein, with unique karyotypic heterogeneity.
Implications:
- The UCI-VULV-1 cell line serves as a valuable in vitro model for investigating the biological properties of HPV-negative squamous vulvar carcinoma.
- Its sensitivity to cis-platinum suggests potential therapeutic strategies for this SCV subtype.
- Further research using this cell line can elucidate mechanisms driving HPV-negative SCV progression and inform clinical treatment approaches.